Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
KRON | US
-0.04
-3.63%
Healthcare
Biotechnology
30/06/2024
17/10/2024
0.93
0.95
0.96
0.90
Kronos Bio Inc. a clinical-stage biopharmaceutical company focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidates are KB-0742 an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors which is in phase 1/2 clinical trial; and Lanraplenib a next-generation SYK inhibitor to treat the patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. The company was incorporated in 2017 and is headquartered in San Mateo California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
54.0%1 month
58.2%3 months
53.7%6 months
93.1%-
-
0.45
0.22
0.17
0.81
-
-
-94.24M
56.07M
56.07M
-
-649.00
-
44.20
-63.00
8.29
1.56
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.15
Range1M
0.19
Range3M
0.61
Rel. volume
0.42
Price X volume
27.42K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
iShares MSCI Brazil ETF USD Acc | CSBR | Biotechnology | 4.44 | 60.36M | -2.63% | n/a | -2140.66% |
Kezar Life Sciences Inc | KZR | Biotechnology | 0.816 | 59.54M | -8.80% | n/a | 11.69% |
Omega Therapeutics Inc. Common Stock | OMGA | Biotechnology | 1.04 | 59.05M | 14.96% | n/a | 483.39% |
RAPT THERAPEUTICS INC. | RAPT | Biotechnology | 1.69 | 58.99M | -3.43% | n/a | 5.24% |
CEL-SCI Corporation | CVM | Biotechnology | 0.95 | 58.42M | -3.57% | n/a | 143.19% |
Allakos Inc | ALLK | Biotechnology | 0.65 | 57.75M | -1.28% | n/a | 47.30% |
CELU | CELU | Biotechnology | 2.6 | 57.16M | -6.47% | n/a | 159.71% |
Actinium Pharmaceuticals Inc | ATNM | Biotechnology | 1.72 | 53.59M | 2.38% | n/a | 4.22% |
OncoCyte Corporation | OCX | Biotechnology | 3.12 | 53.39M | 0.32% | n/a | 16.15% |
Atara Biotherapeutics Inc | ATRA | Biotechnology | 9.38 | 53.22M | 1.96% | n/a | -81.03% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.81 | 0.53 | Expensive |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 0.45 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 53.73 | 72.92 | Lower Risk |
Debt to Equity | 0.22 | -1.24 | Expensive |
Debt to Assets | 0.17 | 0.25 | Cheaper |
Market Cap | 56.07M | 3.78B | Emerging |